(2026). Validation and Functional Exploration of Exosome-Derived ITGA9-AS1 and WNT5A-AS1 as Candidate Diagnostic Biomarkers for Schizophrenia. Neuropsychiatric Disease and Treatment.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Validation and Functional Exploration of Exosome-Derived ITGA9-AS1 and WNT5A-AS1 as Candidate Diagnostic Biomarkers for Schizophrenia."
Neuropsychiatric Disease and Treatment 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Validation and Functional Exploration of Exosome-Derived ITGA9-AS1 and WNT5A-AS1 as Candidate Diagnostic Biomarkers for Schizophrenia."
Neuropsychiatric Disease and Treatment, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.